Soiken Holdings Inc.

Tokyo Stock Exchange 2385.T

Soiken Holdings Inc. Net Cash Used Provided By Financing Activities for the year ending June 30, 2024: USD -1.62 M

Soiken Holdings Inc. Net Cash Used Provided By Financing Activities is USD -1.62 M for the year ending June 30, 2024, a -79.93% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.

Soiken Holdings Inc. Net Cash Used Provided By Financing Activities for the year ending June 30, 2023 was USD -902.12 K, a 5.73% change year over year.
Soiken Holdings Inc. Net Cash Used Provided By Financing Activities for the year ending June 30, 2022 was USD -956.91 K, a 18.99% change year over year.
Soiken Holdings Inc. Net Cash Used Provided By Financing Activities for the year ending June 30, 2021 was USD -1.18 M, a -24.28% change year over year.
Soiken Holdings Inc. Net Cash Used Provided By Financing Activities for the year ending June 30, 2020 was USD -950.42 K, a -97.54% change year over year.

Key data

Date	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure	Effect Of Forex Changes On Cash

Tokyo Stock Exchange: 2385.T

Soiken Holdings Inc.

CEO	Kentaro Ishigami
IPO Date	Dec. 18, 2003
Location	Japan
Headquarters	Senri Life Science Center
Employees	90
Sector	Healthcare
Industries Biotechnology Clinical Trials Cosmetics Dental Care Non-Alcoholic Beverages Personal Care Pharmaceuticals Vaccines

Description

Soiken Holdings Inc. engages in the development of biomarkers in Japan. The company is involved in the development and sale of cosmetics and dietary supplements; licensing and development of biomarker technology; provision of marketing research and post-marketing surveys for dietary supplements; and research, development, and sale of functional materials, such as lactoferrin, as well as pharmaceutical products from ascochlorin derivatives. It also provides clinical evaluation tests for foodstuffs using biomarker technology; support for physician-led pharmaceutical clinical research, health checkups, and specific health guidance; and services to health insurance societies, including contracted health guidance, specific health checkup promotion services for the dependents of insured, and service to prevent diabetes. Soiken Holdings Inc. was incorporated in 1994 and is headquartered in Toyonaka, Japan.

Key trends

Past 5 years